Home
|
Inbox
|
Search
|
Event
B33 - COPD: MAINTENANCE THERAPY
Location: ATS POSTER SESSION
Session Type: Thematic Poster Session
Monday
May
21
9:15 AM
4:15 PM
Presentation(s)
- Single Inhaler Extrafine Triple Therapy Improves Clinical Outcomes in Gold B COPD Patients...
05-21-2018 11:15 AM - 1:00 PM - Efficacy and Safety of Long-Acting β-Agonist/Long-Acting Muscarinic Antagonist Combination...
05-21-2018 11:15 AM - 1:00 PM - Single Inhaler Extrafine Triple Therapy Vs Indacaterol/Glycopyrronium in COPD Patients Pre...
05-21-2018 11:15 AM - 1:00 PM - Failure of Removal of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmona...
05-21-2018 11:15 AM - 1:00 PM - Long-Term Consequences of Clinically Important Deterioration in Patients with Chronic Obst...
05-21-2018 11:15 AM - 1:00 PM - Incidence of Chronic Obstructive Pulmonary Disease Symptom-Defined Exacerbations: Explorat...
05-21-2018 11:15 AM - 1:00 PM - Device-Specific Suboptimal Peak Inspiratory Flow Rates Are Common in Chronic Obstructive P...
05-21-2018 11:15 AM - 1:00 PM - Safety of Tiotropium/Olodaterol in Chronic Obstructive Pulmonary Disease: Pooled Analysis ...
05-21-2018 11:15 AM - 1:00 PM - Efficacy of Indacaterol/Glycopyrronium Versus Salmeterol/Fluticasone by Gender in Patients...
05-21-2018 11:15 AM - 1:00 PM - Absorption, Distribution, Metabolism, and Excretion of Revefenacin, a Long-Acting Muscarin...
05-21-2018 11:15 AM - 1:00 PM - Risk of Pneumonia and Exacerbations with Single Inhaler Extrafine Triple Therapy Compared ...
05-21-2018 11:15 AM - 1:00 PM - Effectiveness and Safety of Direct Switch to Indacaterol/Glycopyrronium from Previous Trea...
05-21-2018 11:15 AM - 1:00 PM - Use of Pulmonary Function Testing to Predict Successful Inhaler Device Technique [Board No...
05-21-2018 11:15 AM - 1:00 PM - Safety Profile of Roflumilast in a Real Life Experience [Board No. P1343]
05-21-2018 11:15 AM - 1:00 PM - LAMA/LABA Fixed Combinations for COPD Management: A Systematic Comparative Review [Board N...
05-21-2018 11:15 AM - 1:00 PM - A Randomized, Double Dummy, Crossover Study Comparing the Bronchodilator Effect of Formote...
05-21-2018 11:15 AM - 1:00 PM - Seebri™ Neohaler® (Glycopyrrolate) Versus Placebo in Patients with Moderate to Severe COPD...
05-21-2018 11:15 AM - 1:00 PM - Seebri™ Neohaler® (Glycopyrrolate) Versus Placebo in Patients with Moderate to Severe COPD...
05-21-2018 11:15 AM - 1:00 PM - Assessment of Internal Medicine Residents’ Knowledge of Common Inhaler Identification and ...
05-21-2018 11:15 AM - 1:00 PM - Inhaler Use Confidence and Treatment Adherence Among Chronic Obstructive Pulmonary Disease...
05-21-2018 11:15 AM - 1:00 PM - Effects of Inhaled Corticosteroids on Distal Airway Inflammation in COPD Patients: The DIS...
05-21-2018 11:15 AM - 1:00 PM - Low Oral Bioavailability of RPL554, a First-in-Class Dual PDE3/4 Inhibitor, Demonstrates t...
05-21-2018 11:15 AM - 1:00 PM - Impact of Patient Age on the Efficacy and Safety of Inhaled Umeclidinium/Vilanterol in Chr...
05-21-2018 11:15 AM - 1:00 PM - Population Pharmacokinetic Analysis of Single Inhaler Triple Therapy (ICS/LAMA/LABA) Versu...
05-21-2018 11:15 AM - 1:00 PM - Revefenacin, a Long-Acting Muscarinic Antagonist (LAMA), Does Not Prolong QT Interval in H...
05-21-2018 11:15 AM - 1:00 PM - Salmeterol Combined with Fluticasone Reduces Exacerbations More Effectively in Chronic Bro...
05-21-2018 11:15 AM - 1:00 PM - Extrafine Formulation of Beclometasone Dipropionate, Formoterol Fumarate, Glycopyrronium (...
05-21-2018 11:15 AM - 1:00 PM - Reduction in Fatal Events with ICS-containing Medications: Results of Safety Pooled Analys...
05-21-2018 11:15 AM - 1:00 PM - Facilitator
05-21-2018 11:15 AM - 1:00 PM - Facilitator
05-21-2018 11:15 AM - 1:00 PM - Facilitator
05-21-2018 11:15 AM - 1:00 PM - Facilitator
05-21-2018 11:15 AM - 1:00 PM
|
Home
|
Inbox
|
Search
|